Protocols · Literature reference

Guide to reported doses, use and effects

Choose a compound from the catalog and check its three dose levels reported in the literature (low, medium and high), how it is administered, its benefits and effects, and —for blends— exactly what the vial contains. Reference material for researchers: information, not a recommendation for use.

For reference only. The dose ranges are values reported in the scientific literature, for information and research purposes: they are not dose recommendations or medical advice. Products are sold labeled for research only. If in doubt, consult a healthcare professional.

Type to filter or use the menu. The information is literature reference, not a recommendation.

Doses reported in the literature
Dosis baja
Dosis media
Dosis alta

Frecuencia:

💡

How it is used

✓

Beneficios reportados

ⓘ

Efectos secundarios reportados

More scientific details
Mechanism

Research areas

Referencia / contexto

Nota:
View product →
Select a compound to see its doses, use, benefits and effects reported in the literature.

How to get the most out of this guide

The three levels (low, medium and high) are literature references, not a prescription. In research the general rule is to start with the lowest dose and increase slowly: that way injection site reactions and, with GLP-1 analogs, digestive discomfort are better tolerated.

🧪

Proper reconstitution

Use bacteriostatic water; let the stream slide down the wall of the vial, do not shoot it onto the powder, and do not shake (swirl gently). The peptide is fragile.

View reconstitution guide →
❄️

Storage

Lyophilized powder lasts a long time refrigerated and protected from light. Once reconstituted, it goes in the refrigerator and is used within the stability window. Avoid freezing what has been reconstituted.

View storage guide →
💉

Subcutaneous (SC) technique

Most are applied SC with an insulin syringe, in a skin fold (abdomen, thigh or arm), with aseptic technique. Rotate the site with each application to avoid irritation or lumps.

🧭

Routes of administration

SC subcutaneous (the most common) · IM intramuscular · Intranasal (some nootropics) · IV only in a clinical setting. Each product sheet indicates its route.

Notice. All NeoPeptidos material is for research use only (RUO). The ranges come from the literature and research protocols; they do not constitute medical advice or an indication for human or veterinary use. Questions about a compound? Message us on WhatsApp or check the catalog.